Canada: Canadian Patent Term Extension - Bill Is In The House

Last Updated: November 10 2016
Article by Noel Courage

Canada and Europe finally signed off on the Comprehensive Economic and Trade Agreement ("CETA"). Its most significant aspect for the pharma industry is prospect of increased drug patent terms by up to 2 years. Not long after the ink was dry on CETA, an amendment (implementation) Bill was introduced into Canadian Parliament on October 31, 2016. This Bill is the first concrete domestic legislative step toward becoming a law1.

Background on CETA

CETA was the product of several years of negotiations. It is a wide-ranging trade agreement covering diverse topics such as foreign ownership and investments, access to public procurement contracts, automobiles, food (e.g. beef and dairy products) and agriculture. Pharmaceuticals were also a prominent part of the discussion.

Patent Term Extension - Supplementary Protection Certificate

Patents give companies the exclusive right to use an invention for a time period, typically up to 20 years from the patent filing date. A maximum two years of additional patent rights for an approved drug will be available by way of a Supplementary Protection Certificate ("SPC")2. The proposed Canadian SPC system is based on the European SPC system. It provides the same practical effect as as a patent term extension, but the additional patent protection is effected by the SPC. The SPC is limited to the particular medicine that is an approved drug (for example, if the patent covers non-commercialized drugs, the non-commercialized drugs will not be protected further). The additional SPC patent protection will be capped at a maximum of 2 years, as discussed in more detail below.

What drugs and patents qualify?

Eligible drugs are defined broadly to include human and veterinary drugs3. This article will focus on human SPC issues. If the same drug is useful for both purposes, they are to be treated as different drugs for purposes of the SPC rules4. Variants of a drug will be treated the same (ie. only one SPC, per drug)5. Reissued patents are also eligible for an SPC6.

The SPC is available upon request of the brand name company, for a patent filed on or after October 1, 19897. The patent will have to pertain to a medicinal ingredient, or a combo, that was authorized after a cut-off date to be set by government8. Drugs approved for sale in Canada prior to this cut-off date will not be eligible to apply for a SPC. The SPC is only available where the drug is being approved by Health Canada (Canada's equivalent of the US FDA) for the first time9. There will be no stacking of multiple SPC's – one SPC for one patent per drug.

The SPC Application Process

The main deadline to file an application for SPC protection will be based on a time period to be set by government regulation in future10. The time period will start to run on the day that Canadian marketing authorization is granted by Health Canada (assuming the patent is granted on that date; otherwise, the time period will start to run later, from the date of patent grant).

To qualify for the SPC, there also appears to be a limited time period to file a new drug submission in Canada after filing a corresponding drug submission is filed in certain other countries11. This time period will start to run from the date of filing of the corresponding foreign new drug submission. This is intended to encourage companies to promptly file a new drug submission in Canada. It also appears to be a risk for companies to lose the option for Canadian SPC protection, by not paying attention to the timing requirements.

Where there are multiple patents, the brand name company has the flexibility to select the benefiting patent for the drug. Only one patent can be the subject of an SPC12. Eligible patents will include one or more claims, such as to a product per se (ie. active ingredient alone or in a combination), a process to obtain a product or the use of a product (eg. medical treatment)13.

The SPC Rights and Term

The SPC will set out the patent number, identify the drug, as well as the starting and end dates of the SPC protection. It takes effect after the patent expiry date. The term is for a maximum of two years, but may be shorter depending on the patent issue date and how quickly regulatory review proceeded at Health Canada14. Health Canada may shorten the SPC term if it believes that the Applicant delayed getting its marketing authorization to try to increase SPC term. Price regulation will continue to apply during the SPC term15.

The usual exceptions to infringement for work relating to development of information for a regulatory submission continue to apply. There is an additional exception to infringement for generic drugs to be exported, which was a carve-out promised by Canada to benefit its generic drug industry16.

The SPC is transferrable along with the corresponding whole or a part of the patent.

SPC is presumed valid in litigation17. An SPC infringement action may be brought in the same manner as a patent infringement action18. If the underlying patent is found invalid in court, the SPC is also void19. The Federal Court of Canada has jurisdiction to rule an SPC void20.

Next Steps

The Bill goes through additional readings in the House of Parliament before it is passed as a law and comes into force. There are likely to be some edits to the Bill along the way, though the substance of the SPC itself is unlikely to change much. There are still a number of important gaps to be filled in by regulators relating to timelines and other issues, and we will provide updates on those issues in future.

Click here for our article on changes to patent litigation under the Bill.


1 Bill C-30, An Act to implement the Comprehensive Economic and Trade Agreement between Canada and the European Union and its Member States and to provide for certain other measures, First Session, Forty-second Parliament,64-65 Elizabeth II, 2015-2016 (first reading October 31, 2016).

2 These new rules will are in s. 50 of the amending Act. They are currently intended to be inserted in the Patent Act as Sections 104 onward. The SPC grant is enabled by s.110.

3 "drug" drug means a substance or a mixture of substances manufactured, sold or represented for use in 15

(a) the diagnosis, treatment, mitigation or prevention of a disease, disorder or abnormal physical state, or its

symptoms, in human beings or animals; or (b) restoring, correcting or modifying organic functions in human beings or animals.

4 S.105(2).

5 S. 105(5).

6 S. 47(1.1), s.105(1).

7 S.106(b).

8 S.106(c).

9 S.106(d).

10 S.106(3).

11 S. 106(f). The other countries will be identified by future regulation.

12 S. 106(6). There is also a process to resolve competing claims for an SPC.

13 S. 124. Regulation will set out the categories of patents more specifically, but prior government guidance indicated it will include at least those noted in this article.

14 The SPC term is calculated by subtracting five years from the patent application filing date and ending on the date of the Health Canada marketing authorization (two years maxium). To get an SPC, the calculation must not produce a zero or negative value.

15 See the Bill starting at s.46.

16 S.115(2).

17 S.116(1).

18 S.124.

19 S.125.

20 S.110(1). See also s. 128 of the Bill re amendments to the Federal Courts Act to give the FCC jurisidiction over SPC issues generally.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions